CORDIS
EU research results

CORDIS

English EN

Networking Activities for Nanotechnology-Facilitated Cancer Theranostics

Project information

Grant agreement ID: 952259

Status

Grant agreement signed

  • Start date

    1 January 2021

  • End date

    31 December 2023

Funded under:

H2020-EU.4.b.

  • Overall budget:

    € 899 823,75

  • EU contribution

    € 899 823,75

Coordinated by:

BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS

Serbia

Objective

The main goal of NANOFACTS is to efficiently overcome the networking gaps and deficiencies in research capabilities and collaboration regarding research in cancer theranostics nanomaterials and biosensing diagnostics of cancer, between BIOS and the partner institutions, internationally-leading counterparts at EU level, leading to the enhanced scientific and
technological (S&T) capacity of all the participating institutions with a principal focus on BIOS. In order to widen the research agenda at BIOS with cancer-related research and health-related biosensing technologies, NANOFACTS will harness and improve pre-existing links with two leading European research institutions in the field of nanotechnology and development of biosensors:
• Trinity College Dublin (TCD), Ireland, The School of Pharmacy and Pharmaceutical Sciences, an expert in application of nanotechnology for cancer treatment and imaging; and its validation, including biocompatibility of nanoparticles/nanodevices.
• Vienna University of Technology (TUW), Faculty of Technical Chemistry, Institute of Applied Synthetic Chemistry
and Institute of Chemical Technologies and Analytics, an expert in devising health-related biosensors.
The main strategies to be explored during the project activities will include:
a) BIOS researchers gaining knowledge on devising theranostic nanoparticles for real-time in vivo detection of cancer biomarkers, along with simultaneous targeted cancer therapy and imaging and b) enhancing the capacity of biosensing technologies at BIOS with cancer-related biosensing, including construction of an array of user-friendly personalized point of-care microfluidic and electronic diagnostic devices for electronic and optical sensing of cancer biomarkers, which could be introduced to home disease-monitoring.
Complementarity of the consortium is based on the diversity of the expertise, knowledge and access to the stakeholder communities required for the success of the project.

Coordinator

BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS

Address

Dr Zorana Dindica Street 1
21000 Novi Sad

Serbia

Activity type

Research Organisations

EU Contribution

€ 411 500

Participants (2)

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Ireland

EU Contribution

€ 257 657,50

TECHNISCHE UNIVERSITAET WIEN

Austria

EU Contribution

€ 230 666,25

Project information

Grant agreement ID: 952259

Status

Grant agreement signed

  • Start date

    1 January 2021

  • End date

    31 December 2023

Funded under:

H2020-EU.4.b.

  • Overall budget:

    € 899 823,75

  • EU contribution

    € 899 823,75

Coordinated by:

BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS

Serbia